Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
75 0% |
 |
Gilead SciencesGILD |
52 0% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| May 2025 | 81 | |
| Apr 2025 | 100 | |
| Mar 2025 | 100 | |
| Feb 2025 | 100 | |
| Jan 2025 | 100 |
How do employees feel about the future at Pliant Therapeutics?
The Business Outlook at Pliant Therapeutics is positive according to its employees. The average outlook rating 81 (out of 100) is high.
Analyzing Business Outlook, how is Pliant Therapeutics performing compared to its industry peers?
Pliant Therapeutics overperforms a majority of its industry peers when it comes to Business Outlook, ranking in the 81st percentile.
How has the business outlook at Pliant Therapeutics changed over the last couple of months
In recent months, Pliant Therapeutics' employees have reported a shift towards a more negative business outlook, suggesting declining company morale and potentially leading to decreased market competitiveness and diminished company performance.
Why is it important to track the business outlook at Pliant Therapeutics?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Pliant Therapeutics.
